Emaai Pharma Ltd. - Due diligence report

A 360° intelligence report on Emaai Pharma Ltd.: trust score, financial health, credit view, compliance, directors, growth and distress sign…

1992-05-19 Mumbai, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Emaai Pharma Ltd. — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Emaai Pharma Ltd. is assessed as Moderate with a Trust Score of 74/100. Emaai Pharma Ltd. is an active public limited indian non-government company incorporated in 1992, operating in the Chemicals sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 19 Oct 2026 from the latest processed filings. Emaai Pharma Ltd. snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
58/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 58/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Flagged by authority: BSE.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MADAN INDERMAL JAIN 01234567 Director 01/04/2018 6 yrs Approved
KIRAN MADHUKAR SAWANT 01234567 Director 01/04/2018 6 yrs Approved
SHARAD LALJI SINGH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 90
Growth signals & trust indicators
Operating for 34+ years.
Distress signals & risk flags
Compliance score is weak (58/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment53/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view60/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 10 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
25 Sep 2018
Director ceased
KIRAN MADHUKAR SAWANT
Director ceased
SHARAD LALJI SINGH
08 Nov 2017
Director ceased
ARVIND G DESAI
01 Nov 2017
Director appointed
SHARAD LALJI SINGH (Director)
27 Oct 2017
Director ceased
UMESH KASHINATH GAWAND
18 Oct 2017
Director appointed
KIRAN MADHUKAR SAWANT (Director)
19 May 1992
Incorporated
Registered with Roc Mumbai I
Director appointed
MADAN INDERMAL JAIN (Director)
10

Key Observations

Auto-generated from the data above
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
Promoters hold the largest single block of equity as per the FY 2017 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Mermaid Estates Private Limited U45200MH2008PTC184119 Mumbai, Maharashtra
Sunrise Furniture Private Limited U36100MH2006PTC161331 Mumbai, Maharashtra
ANAYA POLYMERS PRIVATE LIMITED U24134MH2004PTC144363 Mumbai, Maharashtra
RADHAKRISHNA MOTORS LLP ACA-6669 Mumbai, Maharashtra
Sano Foods Private Limited U15400MH2008PTC180558 Mumbai, Maharashtra
Fuel Saver Marketing Private Limited U51900MH1998PTC116793 Mumbai, Maharashtra
Bavesh Builders Pvt Ltd U45200MH1981PTC025816 Mumbai, Maharashtra
Ugaoo Agritech Private Limited U74999MH2018PTC307118 Mumbai, Maharashtra
Royal Seas Merchants Private Limited U93000MH2012PTC226873 Mumbai, Maharashtra
Vcl Engineers India Private Limited U28990MH2003PTC139056 Mumbai, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Emaai Pharma Ltd. before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Emaai Pharma Ltd.: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Emaai Pharma Ltd. - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Emaai Pharma Ltd. pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Emaai Pharma Ltd. - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Emaai Pharma Ltd. an active company?

Emaai Pharma Ltd. has MCA status “Active” with a compliance score of 58/100 (Moderate).

Is Emaai Pharma Ltd. financially healthy?

Emaai Pharma Ltd. has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Emaai Pharma Ltd.?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Emaai Pharma Ltd.?

Promoters hold the largest single block of equity - exact percentages are in the full report. 3 active director(s) are on record.

Does Emaai Pharma Ltd. have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Emaai Pharma Ltd. up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 58/100 (Moderate).

Is it risky to lend to Emaai Pharma Ltd.?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.